Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Celiac Disease | Research

Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease

Authors: Iida Ahonen, Pilvi Laurikka, Sara Koskimaa, Heini Huhtala, Katri Lindfors, Katri Kaukinen, Kalle Kurppa, Laura Kivelä

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Vomiting and nausea seem to be relatively specific symptoms related to gluten ingestion in treated celiac disease. However, the overall prevalence and associated factors of these symptoms after chronic gluten exposure at celiac disease diagnosis and acute re-exposure during gluten challenge remain obscure.

Methods

Medical data on 815 adult celiac disease patients were collected at diagnosis from the medical records and through supplementary interviews. An additional 74 patients underwent a three-day (10 g/day) gluten challenge (wheat, barley, rye or a combination of the three grains) while in remission. Prevalence of vomiting/nausea and associated factors were evaluated in both cohorts. A literature review was conducted to summarize earlier studies.

Results

Twenty-eight (3%) patients presented with vomiting at diagnosis. They were less often screen-detected and suffered from extra-intestinal symptoms, and had more often abdominal pain (71% vs. 49%, p = 0.021), diarrhea (61% vs. 40%, p = 0.031), weight loss (36% vs. 17%, p = 0.019) and childhood symptoms (61% vs. 33%, p = 0.002) than those without vomiting (n = 787). The groups were comparable in other clinical-demographic data and in genetic, serological, and histological findings. Short-term gluten challenge provoked vomiting/nausea in 14/74 (19%) patients. They consumed gluten-free oats less often than those without these symptoms (64% vs. 92%, p = 0.017), whereas the groups did not differ in clinical-demographic features at diagnosis, presence of comorbidities, duration of gluten-free diet, or in other symptoms or grain used ingested during the challenge. According to the literature, prevalence of vomiting/nausea at celiac disease diagnosis has varied 3–46% and during gluten challenge 13–61%.

Conclusions

In chronic gluten exposure at celiac disease diagnosis, vomiting was associated with other gastrointestinal symptoms and onset of symptoms already in childhood, whereas regular consumption of oats may increase the tolerance against vomiting/nausea after acute re-exposure in treated celiac disease.
Literature
1.
go back to reference Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5:3.PubMedCrossRef Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5:3.PubMedCrossRef
2.
go back to reference Tanpowpong P, Broder-Fingert S, Katz AJ, Camargo CA. Age-related patterns in clinical presentations and gluten-related issues among children and adolescents with celiac disease. Clin Transl Gastroenterol. 2012;3:e9.PubMedPubMedCentralCrossRef Tanpowpong P, Broder-Fingert S, Katz AJ, Camargo CA. Age-related patterns in clinical presentations and gluten-related issues among children and adolescents with celiac disease. Clin Transl Gastroenterol. 2012;3:e9.PubMedPubMedCentralCrossRef
3.
go back to reference Vivas S, Vaquero L, Rodríguez-Martín L, Caminero A. Age-related differences in celiac disease: specific characteristics of adult presentation. World J Gastrointest Pharmacol Ther. 2015;6:207–12.PubMedPubMedCentralCrossRef Vivas S, Vaquero L, Rodríguez-Martín L, Caminero A. Age-related differences in celiac disease: specific characteristics of adult presentation. World J Gastrointest Pharmacol Ther. 2015;6:207–12.PubMedPubMedCentralCrossRef
4.
go back to reference Catassi C, Gatti S, Lionetti E. World perspective and celiac disease epidemiology. Dig Dis. 2015;33:141–6.PubMedCrossRef Catassi C, Gatti S, Lionetti E. World perspective and celiac disease epidemiology. Dig Dis. 2015;33:141–6.PubMedCrossRef
5.
go back to reference Fuchs V, Kurppa K, Huhtala H, Mäki M, Kekkonen L, Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study. United European Gastroenterol J. 2018;6:567–75.PubMedPubMedCentralCrossRef Fuchs V, Kurppa K, Huhtala H, Mäki M, Kekkonen L, Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study. United European Gastroenterol J. 2018;6:567–75.PubMedPubMedCentralCrossRef
6.
go back to reference Laurikka P, Kivelä L, Kurppa K, Kaukinen K. Review article: Systemic consequences of coeliac disease. Aliment Pharmacol Ther. 2022;56:64–72.CrossRef Laurikka P, Kivelä L, Kurppa K, Kaukinen K. Review article: Systemic consequences of coeliac disease. Aliment Pharmacol Ther. 2022;56:64–72.CrossRef
7.
go back to reference Silvester JA, Graff LA, Rigaux L, Walker JR, Duerksen DR. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2016;44:612–9.PubMedPubMedCentralCrossRef Silvester JA, Graff LA, Rigaux L, Walker JR, Duerksen DR. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2016;44:612–9.PubMedPubMedCentralCrossRef
8.
go back to reference Barratt SM, Leeds JS, Sanders DS. Factors innuencing the type, timing and severity of symptomatic responses to dietary gluten in patients with biopsy-proven coeliac disease. J Gastrointestin Liver Dis. 2013;22:391–6.PubMed Barratt SM, Leeds JS, Sanders DS. Factors innuencing the type, timing and severity of symptomatic responses to dietary gluten in patients with biopsy-proven coeliac disease. J Gastrointestin Liver Dis. 2013;22:391–6.PubMed
9.
go back to reference Tye-Din JA, Daveson AJM, Goldstein KE, Hand HL, Neff KM, Goel G, et al. Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC Med. 2020;18:362.PubMedPubMedCentralCrossRef Tye-Din JA, Daveson AJM, Goldstein KE, Hand HL, Neff KM, Goel G, et al. Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC Med. 2020;18:362.PubMedPubMedCentralCrossRef
10.
go back to reference Popp A, Laurikka P, Czika D, Kurppa K. The role of gluten challenge in the diagnosis of celiac disease: a review. Expert Rev Gastroenterol Hepatol. 2023;17:691–700.PubMedCrossRef Popp A, Laurikka P, Czika D, Kurppa K. The role of gluten challenge in the diagnosis of celiac disease: a review. Expert Rev Gastroenterol Hepatol. 2023;17:691–700.PubMedCrossRef
11.
go back to reference Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology. 2018;154:529–39.PubMedCrossRef Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology. 2018;154:529–39.PubMedCrossRef
12.
go back to reference Daveson AJM, Tye-Din JA, Goel G, Goldstein KE, Hand HL, Neff KM, et al. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Aliment Pharmacol Ther. 2020;51:244–52.PubMedCrossRef Daveson AJM, Tye-Din JA, Goel G, Goldstein KE, Hand HL, Neff KM, et al. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Aliment Pharmacol Ther. 2020;51:244–52.PubMedCrossRef
13.
go back to reference Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, et al. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment Pharmacol Ther. 2019;50:901–10.PubMedCrossRef Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, et al. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment Pharmacol Ther. 2019;50:901–10.PubMedCrossRef
14.
go back to reference Aaltonen K, Laurikka P, Huhtala H, Mäki M, Kaukinen K, Kurppa K. The long-term consumption of oats in celiac disease patients is safe: A large cross-sectional study. Nutrients. 2017;9:611.PubMedPubMedCentralCrossRef Aaltonen K, Laurikka P, Huhtala H, Mäki M, Kaukinen K, Kurppa K. The long-term consumption of oats in celiac disease patients is safe: A large cross-sectional study. Nutrients. 2017;9:611.PubMedPubMedCentralCrossRef
15.
go back to reference Yohannes DA, Freitag TL, de Kauwe A, Kaukinen K, Kurppa K, Wacklin P, et al. Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac disease. Sci Rep. 2017;7:17977.PubMedPubMedCentralCrossRef Yohannes DA, Freitag TL, de Kauwe A, Kaukinen K, Kurppa K, Wacklin P, et al. Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac disease. Sci Rep. 2017;7:17977.PubMedPubMedCentralCrossRef
16.
go back to reference Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med. 2010;2:41–51.CrossRef Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med. 2010;2:41–51.CrossRef
17.
go back to reference Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.PubMedCrossRef Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.PubMedCrossRef
18.
go back to reference Sulkanen S, Collin P, Laurila K, Mäki M. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol. 1998;33:251–4.PubMedCrossRef Sulkanen S, Collin P, Laurila K, Mäki M. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol. 1998;33:251–4.PubMedCrossRef
19.
go back to reference Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137:834–40.PubMedCrossRef Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137:834–40.PubMedCrossRef
20.
go back to reference Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci. 2003;48:761–4.PubMedCrossRef Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci. 2003;48:761–4.PubMedCrossRef
21.
go back to reference Maimaris S, Schiepatti A, Gabrielli GM, Costetti M, Costa S, Sanders DS, et al. Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease. Eur J Gastroenterol Hepatol. 2020;32:1447–51.PubMedCrossRef Maimaris S, Schiepatti A, Gabrielli GM, Costetti M, Costa S, Sanders DS, et al. Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease. Eur J Gastroenterol Hepatol. 2020;32:1447–51.PubMedCrossRef
22.
go back to reference Lima RF, da MariaSilva Kotze L, Kotze LR, Chrisostomo KR, Nisihara R. Gender-related differences in celiac patients at diagnosis. Arch Med Res. 2019;50:437–41.PubMedCrossRef Lima RF, da MariaSilva Kotze L, Kotze LR, Chrisostomo KR, Nisihara R. Gender-related differences in celiac patients at diagnosis. Arch Med Res. 2019;50:437–41.PubMedCrossRef
23.
go back to reference Sansotta N, Amirikian K, Guandalini S, Jericho H. Celiac disease symptom resolution: Effectiveness of the gluten-free diet. J Pediatr Gastroenterol Nutr. 2018;66:48–52.PubMedCrossRef Sansotta N, Amirikian K, Guandalini S, Jericho H. Celiac disease symptom resolution: Effectiveness of the gluten-free diet. J Pediatr Gastroenterol Nutr. 2018;66:48–52.PubMedCrossRef
24.
go back to reference Spijkerman M, Tan IL, Kolkman JJ, Withoff S, Wijmenga C, Visschedijk MC, et al. A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands. Dig Liver Dis. 2016;48:499–505.PubMedCrossRef Spijkerman M, Tan IL, Kolkman JJ, Withoff S, Wijmenga C, Visschedijk MC, et al. A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands. Dig Liver Dis. 2016;48:499–505.PubMedCrossRef
25.
go back to reference Alavinejad P, Hajiani E, Masjedizadeh R, Hashemi SJ, Faramarzi M, Sebghatollahi V, et al. Epidemiologic and demographic survey of celiac disease in Khuzestan province. Middle East J Dig Dis. 2014;6:98–103.PubMedPubMedCentral Alavinejad P, Hajiani E, Masjedizadeh R, Hashemi SJ, Faramarzi M, Sebghatollahi V, et al. Epidemiologic and demographic survey of celiac disease in Khuzestan province. Middle East J Dig Dis. 2014;6:98–103.PubMedPubMedCentral
26.
go back to reference Abbas Z, Raza S, Yakoob J, Abid S, Hamid S, Shah H, et al. Varied presentation of celiac disease in Pakistani adults. J Coll Physicians Surg Pak. 2013;23:522–4.PubMed Abbas Z, Raza S, Yakoob J, Abid S, Hamid S, Shah H, et al. Varied presentation of celiac disease in Pakistani adults. J Coll Physicians Surg Pak. 2013;23:522–4.PubMed
27.
go back to reference Sundar N, Crimmins R, Swift GL. Clinical presentation and incidence of complications in patients with coeliac disease diagnosed by relative screening. Postgrad Med J. 2007;83:273–6.PubMedPubMedCentralCrossRef Sundar N, Crimmins R, Swift GL. Clinical presentation and incidence of complications in patients with coeliac disease diagnosed by relative screening. Postgrad Med J. 2007;83:273–6.PubMedPubMedCentralCrossRef
28.
go back to reference Jones S, D’Souza C, Haboubi NY. Patterns of clinical presentation of adult coeliac disease in a rural setting. Nutr J. 2006;5:24. Jones S, D’Souza C, Haboubi NY. Patterns of clinical presentation of adult coeliac disease in a rural setting. Nutr J. 2006;5:24.
29.
go back to reference Gasbarrini G, Ciccocioppo R, De Vitis I, Corazza GR. Coeliac disease in the elderly: A multicentre Italian study. Gerontology. 2001;47:306–10.PubMedCrossRef Gasbarrini G, Ciccocioppo R, De Vitis I, Corazza GR. Coeliac disease in the elderly: A multicentre Italian study. Gerontology. 2001;47:306–10.PubMedCrossRef
30.
go back to reference Galli G, Amici G, Conti L, Lahner E, Annibale B, Carabotti M. Sex–gender differences in adult coeliac disease at diagnosis and gluten-free-diet follow-up. Nutrients. 2022;14:3192.PubMedPubMedCentralCrossRef Galli G, Amici G, Conti L, Lahner E, Annibale B, Carabotti M. Sex–gender differences in adult coeliac disease at diagnosis and gluten-free-diet follow-up. Nutrients. 2022;14:3192.PubMedPubMedCentralCrossRef
31.
go back to reference Casella S, Zanini B, Lanzarotto F, Villanacci V, Ricci C, Lanzini A. Celiac disease in elderly adults: Clinical, serological, and histological characteristics and the effect of a gluten-free diet. J Am Geriatr Soc. 2012;60:1064–9.PubMedCrossRef Casella S, Zanini B, Lanzarotto F, Villanacci V, Ricci C, Lanzini A. Celiac disease in elderly adults: Clinical, serological, and histological characteristics and the effect of a gluten-free diet. J Am Geriatr Soc. 2012;60:1064–9.PubMedCrossRef
32.
go back to reference Katz KD, Rashtak S, Lahr BD, Melton JL, Krause PK, Maggi K, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333–9.PubMedPubMedCentralCrossRef Katz KD, Rashtak S, Lahr BD, Melton JL, Krause PK, Maggi K, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333–9.PubMedPubMedCentralCrossRef
33.
go back to reference López-Palacios N, Pascual V, Castaño M, Bodas A, Fernández-Prieto M, Espino-Paisán L, et al. Evaluation of T cells in blood after a short gluten challenge for coeliac disease diagnosis. Dig Liver Dis. 2018;50:1183–8.PubMedCrossRef López-Palacios N, Pascual V, Castaño M, Bodas A, Fernández-Prieto M, Espino-Paisán L, et al. Evaluation of T cells in blood after a short gluten challenge for coeliac disease diagnosis. Dig Liver Dis. 2018;50:1183–8.PubMedCrossRef
34.
go back to reference Cartee AK, Choung RS, King KS, Wang S, Dzuris JL, Anderson RP, et al. Plasma IL-2 and symptoms response after acute gluten exposure in subjects with celiac disease or nonceliac gluten sensitivity. Am J Gastroenterol. 2022;117:319–26.PubMedCrossRef Cartee AK, Choung RS, King KS, Wang S, Dzuris JL, Anderson RP, et al. Plasma IL-2 and symptoms response after acute gluten exposure in subjects with celiac disease or nonceliac gluten sensitivity. Am J Gastroenterol. 2022;117:319–26.PubMedCrossRef
35.
go back to reference Murray JA, Syage JA, Wu TT, Dickason MA, Ramos AG, van Dyke C, et al. Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge. Gastroenterology. 2022;163:1510–21.PubMedCrossRef Murray JA, Syage JA, Wu TT, Dickason MA, Ramos AG, van Dyke C, et al. Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge. Gastroenterology. 2022;163:1510–21.PubMedCrossRef
36.
go back to reference Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, et al. A Randomized trial of a transglutaminase 2 inhibitor for celiac disease. N Engl J Med. 2021;385:35–45.PubMedCrossRef Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, et al. A Randomized trial of a transglutaminase 2 inhibitor for celiac disease. N Engl J Med. 2021;385:35–45.PubMedCrossRef
37.
go back to reference Kelly CP, Green PHR, Murray JA, Dimarino A, Colatrella A, Leffler DA, et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study. Aliment Pharmacol Ther. 2013;37:252–62.PubMedCrossRef Kelly CP, Green PHR, Murray JA, Dimarino A, Colatrella A, Leffler DA, et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study. Aliment Pharmacol Ther. 2013;37:252–62.PubMedCrossRef
38.
go back to reference Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014;146:1649–58.PubMedCrossRef Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014;146:1649–58.PubMedCrossRef
39.
go back to reference Kivelä L, Kaukinen K, Huhtala H, Lähdeaho ML, Mäki M, Kurppa K. At-risk screened children with celiac disease are comparable in disease severity and dietary adherence to those found because of clinical suspicion: a large cohort study. J Pediatr. 2017;183:115-121.e2.PubMedCrossRef Kivelä L, Kaukinen K, Huhtala H, Lähdeaho ML, Mäki M, Kurppa K. At-risk screened children with celiac disease are comparable in disease severity and dietary adherence to those found because of clinical suspicion: a large cohort study. J Pediatr. 2017;183:115-121.e2.PubMedCrossRef
40.
go back to reference Langbang D, Dhodapkar R, Parija S, Premarajan K, Rajkumari N. Prevalence of intestinal parasites among rural and urban population in Puducherry, South India - A community-based study. J Family Med Prim Care. 2019;8:1607–12.PubMedPubMedCentralCrossRef Langbang D, Dhodapkar R, Parija S, Premarajan K, Rajkumari N. Prevalence of intestinal parasites among rural and urban population in Puducherry, South India - A community-based study. J Family Med Prim Care. 2019;8:1607–12.PubMedPubMedCentralCrossRef
41.
go back to reference Kang G, Mathew MS, Prasanna Rajan D, Daniel JD, Mathan MM, Mathan VI, et al. Prevalence of intestinal parasites in rural Southern Indians. Trop Med Int Health. 1998;3:70–5.PubMedCrossRef Kang G, Mathew MS, Prasanna Rajan D, Daniel JD, Mathan MM, Mathan VI, et al. Prevalence of intestinal parasites in rural Southern Indians. Trop Med Int Health. 1998;3:70–5.PubMedCrossRef
42.
go back to reference Taavela J, Kurppa K, Collin P, Lähdeaho M, Salmi T, Saavalainen P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11:166–71.PubMedCrossRef Taavela J, Kurppa K, Collin P, Lähdeaho M, Salmi T, Saavalainen P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11:166–71.PubMedCrossRef
43.
go back to reference Kurppa K, Collin P, Viljamaa M, Haimila K, Saavalainen P, Partanen J, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology. 2009;136:816–23.PubMedCrossRef Kurppa K, Collin P, Viljamaa M, Haimila K, Saavalainen P, Partanen J, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology. 2009;136:816–23.PubMedCrossRef
44.
go back to reference Murray JA, Rubio-Tapia A, van Dyke CT, Brogan DL, Knipschield MA, Lahr B, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6:186–93.PubMedCrossRef Murray JA, Rubio-Tapia A, van Dyke CT, Brogan DL, Knipschield MA, Lahr B, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6:186–93.PubMedCrossRef
45.
go back to reference Malamut G, Matysiak-Budnik T, Grosdider E, Jais JP, Morales E, Damotte D, et al. Adult celiac disease with severe or partial villous atrophy: A comparative study. Gastroenterol Clin Biol. 2008;32:236–42.PubMedCrossRef Malamut G, Matysiak-Budnik T, Grosdider E, Jais JP, Morales E, Damotte D, et al. Adult celiac disease with severe or partial villous atrophy: A comparative study. Gastroenterol Clin Biol. 2008;32:236–42.PubMedCrossRef
46.
go back to reference Korczak R, Kocher M, Swanson KS. Effects of oats on gastrointestinal health as assessed by in vitro, animal, and human studies. Nutr Rev. 2020;78:343–63.PubMedCrossRef Korczak R, Kocher M, Swanson KS. Effects of oats on gastrointestinal health as assessed by in vitro, animal, and human studies. Nutr Rev. 2020;78:343–63.PubMedCrossRef
47.
go back to reference Thies F, Masson LF, Boffetta P, Kris-Etherton P. Oats and bowel disease: a systematic literature review. Br J Nutr. 2014;112:S31-43.PubMedCrossRef Thies F, Masson LF, Boffetta P, Kris-Etherton P. Oats and bowel disease: a systematic literature review. Br J Nutr. 2014;112:S31-43.PubMedCrossRef
48.
go back to reference Laurikka P, Lindfors K, Oittinen M, Huhtala H, Salmi T, Lähdeaho ML, et al. Dietary factors and mucosal immune response in celiac disease patients having persistent symptoms despite a gluten-free diet. J Clin Gastroenterol. 2019;53:507–13.PubMedCrossRef Laurikka P, Lindfors K, Oittinen M, Huhtala H, Salmi T, Lähdeaho ML, et al. Dietary factors and mucosal immune response in celiac disease patients having persistent symptoms despite a gluten-free diet. J Clin Gastroenterol. 2019;53:507–13.PubMedCrossRef
49.
go back to reference Bijkerk CJ, de Wit NJ, Muris JWM, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154–b3154.PubMedPubMedCentralCrossRef Bijkerk CJ, de Wit NJ, Muris JWM, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154–b3154.PubMedPubMedCentralCrossRef
51.
go back to reference Leinonen H, Kivelä L, Lähdeaho ML, Huhtala H, Kaukinen K, Kurppa K. Daily life restrictions are common and associated with health concerns and dietary challenges in adult celiac disease patients diagnosed in childhood. Nutrients. 2019;11:1718.PubMedPubMedCentralCrossRef Leinonen H, Kivelä L, Lähdeaho ML, Huhtala H, Kaukinen K, Kurppa K. Daily life restrictions are common and associated with health concerns and dietary challenges in adult celiac disease patients diagnosed in childhood. Nutrients. 2019;11:1718.PubMedPubMedCentralCrossRef
52.
go back to reference Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019;5:7756.CrossRef Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019;5:7756.CrossRef
53.
go back to reference Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, et al. Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity. United European Gastroenterol J. 2020;8:108–18.PubMedCrossRef Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, et al. Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity. United European Gastroenterol J. 2020;8:108–18.PubMedCrossRef
54.
go back to reference Stamnaes J, Stray D, Stensland M, Sarna VK, Nyman TA, Lundin KEA, et al. In well-treated celiac patients low-level mucosal inflammation predicts response to 14-day gluten challenge. Adv Sci. 2021;8:2003526.CrossRef Stamnaes J, Stray D, Stensland M, Sarna VK, Nyman TA, Lundin KEA, et al. In well-treated celiac patients low-level mucosal inflammation predicts response to 14-day gluten challenge. Adv Sci. 2021;8:2003526.CrossRef
55.
go back to reference Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, et al. Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet–treated dermatitis herpetiformis. J Invest Dermatol. 2019;139:2108–14.PubMedCrossRef Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, et al. Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet–treated dermatitis herpetiformis. J Invest Dermatol. 2019;139:2108–14.PubMedCrossRef
Metadata
Title
Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease
Authors
Iida Ahonen
Pilvi Laurikka
Sara Koskimaa
Heini Huhtala
Katri Lindfors
Katri Kaukinen
Kalle Kurppa
Laura Kivelä
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02934-w

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.